|
市場調査レポート
商品コード
1702177
COPDおよび喘息用デバイス市場レポート：製品、適応症、流通チャネル、地域別、2025年～2033年COPD and Asthma Devices Market Report by Product (Inhalers, Nebulizers), Indication (Asthma, COPD), Distribution Channel (Retail Pharmacies, Hospitals, Online Pharmacies), and Region 2025-2033 |
||||||
カスタマイズ可能
|
|||||||
価格
| COPDおよび喘息用デバイス市場レポート：製品、適応症、流通チャネル、地域別、2025年～2033年 |
|
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 図表
- 目次
概要
COPDおよび喘息用デバイス市場の世界市場規模は2024年に478億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに705億米ドルに達し、2025年から2033年の間に4.42％の成長率（CAGR）を示すと予測しています。市場成長の主な要因は、リアルタイムのモニタリング機能を備えたスマート吸入器の継続的な技術進歩、呼吸器疾患の有病率の増加、より正確な薬物送達のための個別化治療オプションの重視の強化、ヘルスケアアクセスの改善による新興市場での需要の増加などです。
慢性閉塞性肺疾患（COPD）は、肺からの気流の閉塞をもたらす炎症性疾患です。その初期症状には、息切れ、喘鳴、胸のつかえ、粘液を伴うか伴わない慢性的な咳、頻繁な風邪、喉の痛みなどがあります。一方、気管支喘息とも呼ばれる喘息は、肺の気道に影響を及ぼす呼吸器疾患です。その症状は息切れ、胸の圧迫感、睡眠障害、咳や喘鳴発作などです。これらの呼吸器疾患は、吸入薬の投与を助けるさまざまな装置を用いて治療されます。COPDおよび喘息用デバイスは、肺ドラッグデリバリーデバイスとしても知られ、呼吸器疾患の恒久的治療やレスキュー療法として使用されます。その結果、世界中で絶大な支持を得ています。
COPDおよび喘息用デバイス市場動向：
慢性呼吸器疾患に罹患しやすい世界の高齢者人口の増加は、市場にプラスの影響を与える主な要因の1つです。また、たばこの喫煙増加による呼吸器疾患の増加も、COPDおよび喘息機器の売上を増加させています。これとは別に、ヘルスケアへの支出の増加とヘルスケア産業における継続的な自動化が市場成長に寄与しています。先進医療ソリューションの普及は、世界中のメーカーに有利な成長機会を提供しています。現在、ヘルスケア開業医や肺疾患専門医は、その迅速かつ効果的な結果を理由に、薬剤と装置の組み合わせを好んでいます。さらに、化学工業の拡大が環境汚染レベルの上昇と呼吸器系の問題を引き起こしており、これが市場を牽引しています。さらに、携帯型ドラッグデリバリーデバイスの導入が市場の成長を促進しています。
本レポートで扱う主な質問
- 2024年の世界COPDおよび喘息用デバイス市場の市場規模は？
- 2025-2033年におけるCOPDおよび喘息用デバイス市場の世界市場予測成長率は？
- COPDおよび喘息用デバイス市場の世界市場を牽引する主要因は何か？
- 世界のCOPDおよび喘息用デバイス市場に対するCOVID-19の影響は？
- 世界のCOPDおよび喘息用デバイス市場の製品別内訳は？
- 世界のCOPDおよび喘息用デバイス市場の適応症別の内訳は？
- 世界のCOPDおよび喘息用デバイス市場の販売チャネル別の内訳は？
- 世界のCOPDおよび喘息用デバイス市場における主要地域は？
- 世界のCOPDおよび喘息用デバイス市場における主要プレイヤー／企業は？
目次
第1章 序文
第2章 調査範囲と調査手法
- 調査の目的
- ステークホルダー
- データソース
- 一次情報
- 二次情報
- 市場推定
- ボトムアップアプローチ
- トップダウンアプローチ
- 調査手法
第3章 エグゼクティブサマリー
第4章 イントロダクション
- 概要
- 主要業界動向
第5章 世界のCOPDおよび喘息用デバイス市場
- 市場概要
- 市場実績
- COVID-19の影響
- 市場予測
第6章 市場内訳：製品別
- 吸入器
- 主要セグメント
- 薬剤粉末吸入器（DPI）
- 定量噴霧式吸入器（MDI）
- ソフトミスト吸入器
- 主要セグメント
- ネブライザー
- 主要セグメント
- コンプレッサー式ネブライザー
- 超音波ネブライザー
- メッシュネブライザー
- 主要セグメント
第7章 市場内訳：適応症別
- 喘息
- COPD
第8章 市場内訳：流通チャネル別
- 小売薬局
- 病院
- オンライン薬局
第9章 市場内訳：地域別
- 北米
- 米国
- カナダ
- アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
- 欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
- ラテンアメリカ
- ブラジル
- メキシコ
- その他
- 中東・アフリカ
- 市場内訳：国別
第10章 SWOT分析
- 概要
- 強み
- 弱み
- 機会
- 脅威
第11章 バリューチェーン分析
第12章 ポーターのファイブフォース分析
- 概要
- 買い手の交渉力
- 供給企業の交渉力
- 競合の程度
- 新規参入業者の脅威
- 代替品の脅威
第13章 価格分析
第14章 競合情勢
- 市場構造
- 主要企業
- 主要企業のプロファイル
- Adherium Limited
- Aristopharma Ltd.
- AstraZeneca PLC
- Baxter International Inc.
- Boehringer Ingelheim International GmbH
- Cohero Health Inc.
- Koninklijke Philips N.V.
- Omron Corporation
- Pari Respiratory Equipment Inc.
- Recipharm AB
- Verona Pharma plc
図表
List of Figures
- Figure 1: Global: COPD and Asthma Devices Market: Major Drivers and Challenges
- Figure 2: Global: COPD and Asthma Devices Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: COPD and Asthma Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 4: Global: COPD and Asthma Devices Market: Breakup by Product (in %), 2024
- Figure 5: Global: COPD and Asthma Devices Market: Breakup by Indication (in %), 2024
- Figure 6: Global: COPD and Asthma Devices Market: Breakup by Distribution Channel (in %), 2024
- Figure 7: Global: COPD and Asthma Devices Market: Breakup by Region (in %), 2024
- Figure 8: Global: COPD and Asthma Devices (Inhalers) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 9: Global: COPD and Asthma Devices (Inhalers) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 10: Global: COPD and Asthma Devices (Nebulizers) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 11: Global: COPD and Asthma Devices (Nebulizers) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 12: Global: COPD and Asthma Devices (Asthma) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 13: Global: COPD and Asthma Devices (Asthma) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 14: Global: COPD and Asthma Devices (COPD) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 15: Global: COPD and Asthma Devices (COPD) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 16: Global: COPD and Asthma Devices (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 17: Global: COPD and Asthma Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 18: Global: COPD and Asthma Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 19: Global: COPD and Asthma Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 20: Global: COPD and Asthma Devices (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 21: Global: COPD and Asthma Devices (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 22: North America: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 23: North America: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 24: United States: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 25: United States: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 26: Canada: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 27: Canada: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 28: Asia-Pacific: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 29: Asia-Pacific: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 30: China: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 31: China: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 32: Japan: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 33: Japan: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 34: India: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: India: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: South Korea: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: South Korea: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: Australia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 39: Australia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 40: Indonesia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: Indonesia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: Europe: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: Europe: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: Germany: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: Germany: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: France: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: France: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: United Kingdom: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: United Kingdom: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: Italy: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: Italy: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: Spain: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 55: Spain: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 56: Russia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: Russia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: Latin America: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: Latin America: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: Brazil: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: Brazil: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: Mexico: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: Mexico: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: Middle East and Africa: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: Middle East and Africa: COPD and Asthma Devices Market: Breakup by Country (in %), 2024
- Figure 70: Middle East and Africa: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 71: Global: COPD and Asthma Devices Industry: SWOT Analysis
- Figure 72: Global: COPD and Asthma Devices Industry: Value Chain Analysis
- Figure 73: Global: COPD and Asthma Devices Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: COPD and Asthma Devices Market: Key Industry Highlights, 2024 & 2033
- Table 2: Global: COPD and Asthma Devices Market Forecast: Breakup by Product (in Million USD), 2025-2033
- Table 3: Global: COPD and Asthma Devices Market Forecast: Breakup by Indication (in Million USD), 2025-2033
- Table 4: Global: COPD and Asthma Devices Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
- Table 5: Global: COPD and Asthma Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 6: Global: COPD and Asthma Devices Market: Competitive Structure
- Table 7: Global: COPD and Asthma Devices Market: Key Players
目次
Product Code: SR112025A6126
The global COPD and asthma devices market size reached USD 47.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 70.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.42% during 2025-2033. The market growth is primarily driven by continual technological advancements in smart inhalers with real-time monitoring capabilities, growing prevalence of respiratory conditions, an enhanced emphasis on personalized treatment options for more accurate drug delivery and increasing demand in emerging markets due to improved healthcare access.
Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that leads to obstructed airflow from the lungs. Its early symptoms include shortness of breath, wheezing, chest tightness, chronic cough with or without mucus, frequent cold, and throat soreness. On the other hand, asthma, also known as bronchial asthma, is a respiratory disorder that affects the airways in the lungs. Its symptoms are shortness of breath, chest tightness, trouble sleeping, and coughing or wheezing attacks. These respiratory diseases are treated using various devices that help deliver inhaled medication. COPD and asthma devices, also known as pulmonary drug delivery devices, are used as permanent treatment or rescue therapy for respiratory diseases. As a result, they are gaining immense traction across the globe.
COPD and Asthma Devices Market Trends:
The growing global geriatric population, which is highly susceptible to chronic respiratory disorders, represents one of the key factors positively influencing the market. In addition, rising occurrences of respiratory diseases caused due to the rising smoking of cigarettes are increasing the sales of COPD and asthma devices. Apart from this, the increasing expenditure on healthcare and continuous automation in the healthcare industry are contributing to the market growth. The widespread adoption of advanced medical solutions is offering lucrative growth opportunities to manufacturers across the globe. At present, healthcare practitioners and pulmonary diseases specialists are preferring a combination of a drug and a device on account of their fast and effective outcome. Furthermore, the expansion of chemical industries is resulting in the rising environmental pollution level and breathing problems, which, in turn, is driving the market. Additionally, the introduction of portable drug delivery devices is propelling the market growth.
Key Market Segmentation:
Breakup by Product:
- Inhalers
- Drug Powdered Inhalers (DPIs)
- Metered Dose Inhalers (MDIs)
- Soft Mist Inhalers
- Nebulizers
- Compressor Nebulizers
- Ultrasonic Nebulizers
- Mesh Nebulizers
Breakup by Indication:
- Asthma
- COPD
Breakup by Distribution Channel:
- Retail Pharmacies
- Hospitals
- Online Pharmacies
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Adherium Limited, Aristopharma Ltd., AstraZeneca PLC, Baxter International Inc., Boehringer Ingelheim International GmbH, Cohero Health Inc., Koninklijke Philips N.V., Omron Corporation, Pari Respiratory Equipment Inc., Recipharm AB and Verona Pharma plc.
Key Questions Answered in This Report
- 1.What was the size of the global COPD and asthma devices market market in 2024?
- 2.What is the expected growth rate of the global COPD and asthma devices market during 2025-2033?
- 3.What are the key factors driving the global COPD and asthma devices market?
- 4.What has been the impact of COVID-19 on the global COPD and asthma devices market?
- 5.What is the breakup of the global COPD and asthma devices market based on the product?
- 6.What is the breakup of the global COPD and asthma devices market based on the indication?
- 7.What is the breakup of the global COPD and asthma devices market based on distribution channel?
- 8.What are the key regions in the global COPD and asthma devices market?
- 9.Who are the key players/companies in the global COPD and asthma devices market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global COPD and Asthma Devices Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Inhalers
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Drug Powdered Inhalers (DPIs)
- 6.1.2.2 Metered Dose Inhalers (MDIs)
- 6.1.2.3 Soft Mist Inhalers
- 6.1.3 Market Forecast
- 6.2 Nebulizers
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Compressor Nebulizers
- 6.2.2.2 Ultrasonic Nebulizers
- 6.2.2.3 Mesh Nebulizers
- 6.2.3 Market Forecast
7 Market Breakup by Indication
- 7.1 Asthma
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 COPD
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Retail Pharmacies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Hospitals
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Online Pharmacies
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Adherium Limited
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Aristopharma Ltd.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 AstraZeneca PLC
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Baxter International Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Boehringer Ingelheim International GmbH
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Cohero Health Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Koninklijke Philips N.V.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Omron Corporation
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Pari Respiratory Equipment Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Recipharm AB
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 Verona Pharma plc
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.1 Adherium Limited
